Le Lézard
Classified in: Environment, Health, Business
Subject: JVN

OPG and BWXT Make Significant Progress in Production of Life-Saving Medical Isotope at Darlington Nuclear Generating Station

Darlington to become first large-scale nuclear station to produce molybdenum-99

PETERBOROUGH, ON, Sept. 24, 2020 /CNW/ - Ontario Power Generation (OPG), its subsidiary Laurentis Energy Partners (Laurentis), BWXT ITG Canada Inc. and its affiliates (BWXT) are making significant progress toward the production of molybdenum-99 (Mo-99) at OPG's Darlington Nuclear Generating Station. Mo-99 is a much-needed medical isotope used in over 40 million procedures a year to detect cancers and diagnose various medical conditions.

Over the past 24 months, a team of more than 100 personnel at BWXT and Laurentis designed specialized tooling at BWXT's facility in Peterborough to enable the production of Mo-99 at Darlington. The manufacturing of this specialized tooling is currently underway at the same BWXT facility in Peterborough.

BWXT has also built a fabrication facility at its current location in Peterborough to produce Mo-99 components that will be delivered by the specialized tooling, which will be installed at Darlington. The tooling will deliver the molybdenum into the Darlington reactor for irradiation, which will enable Darlington to become the first commercial operating nuclear reactor to produce Mo-99.

"This advanced equipment is an example of how Laurentis is maximizing decades of experience within the nuclear industry for the delivery of innovative solutions," said Dominique Minière, President of Laurentis Energy Partners. "These milestones represent a considerable step forward in the implementation of this industry-leading technology."

"We are leveraging BWXT's broad capabilities to design, manufacture, install and service reactor technology in order to support the launch of this innovative solution in partnership with Laurentis," said John MacQuarrie, President of BWXT Canada Ltd. "Together, we have made tremendous progress towards the production of this crucial medical isotope that is used in more than 80 per cent of all nuclear medicine procedures."

"We are well underway with the transformation of our nuclear medicine facility in Ottawa to be able to process Mo-99 and manufacture Tc-99m generators," said Martyn Coombs, President of BWXT ITG. "These generators will be used to make radiopharmaceuticals for patients, and will help to resolve historical shortages of this vital product."

"Over the last 10 years, there has been a reduction in the accessibility of radioisotopes and this supply issue has only been exacerbated with the onset of COVID," said Jean Nash, Clinical Manager, Molecular Imaging, University Health Network. "A new, reliable supply will allow for more stable access to medical isotopes and support hospitals and clinicians in Ontario, Canada and beyond to provide better patient care."

About BWXT Canada Ltd.

BWXT Canada Ltd. (BWXT Canada) has over 60 years of expertise and experience in the design, manufacturing, commissioning and service of nuclear power generation equipment. This includes steam generators, nuclear fuel and fuel components, critical plant components, parts and related plant services. BWXT Canada's sister company, BWXT ITG Canada, Inc. (BWXT ITG) provides its customers, who conduct life-saving medical procedures for patients around the world, the benefit of decades of experience in the development, manufacturing, packaging and delivery of medical isotopes and radiopharmaceuticals. Headquartered in Cambridge, Ontario, BWXT in Canada has approximately 1,500 employees at locations in Cambridge, Dundas, Peterborough, Toronto, Arnprior, Pickering, Port Elgin, Owen Sound, Kanata and Oakville, Ontario, and Vancouver, British Columbia. BWXT Canada is a subsidiary of BWX Technologies, Inc. (NYSE: BWXT). Follow us on Twitter @BWXTech and learn more at www.bwxt.com.

About Laurentis Energy Partners:

Laurentis Energy Partners a wholly owned subsidiary of Ontario Power Generation formed in 2012. Laurentis is an industry leading provider of inspection, maintenance, engineering, and project management services for the nuclear, and hydroelectric power generation industries. Laurentis services its base of international clients from offices in Toronto, Ontario; Pickering, Ontario; Tiverton, Ontario; Saint John, New Brunswick and Bucharest, Romania.

About OPG:

OPG is a climate change leader and the largest clean energy electricity generator in the province, providing almost half of the power Ontarians rely on every day. It is also one of the most diverse generators in North America, with expertise in nuclear, hydroelectric, biomass, solar and natural gas technologies.

 follow us @OPG

SOURCE Ontario Power Generation Inc.

These press releases may also interest you

at 11:48
Precision Genetics, a leading healthcare technology company and high capacity molecular testing lab, has added saliva collection to their existing portfolio of validated Covid-19 testing options submitted under Emergency Use Authorization (EUA) by...

at 11:45
SureClinical, the premier provider of FDA and EU compliance validated eClinical cloud applications today announced its complimentary support for Accelagen Pty Ltd Phase 1/2 COVID-19 trial on the SureClinical Platform. Accelagen is an Australian-based...

at 11:41
Breast, colon, prostate, and lung cancers did not stop for COVID-19 in 2020, but screenings and treatments did. Dramatically. The result, say doctors, could be a catastrophe in the making. A new study published online ahead of the November issue of...

at 11:40
More than 61 percent1 of Americans are afflicted with gastrointestinal symptoms ranging from upset stomach and diarrhea to bloating and abdominal pain. Millions of these patients are misdiagnosed, untreated, and frustrated by lack of medical insight...

at 11:39
Fighting COVID-19 is taking an undue toll on emergency physicians. A teleconference hosted on Monday, October 26 at 3:30 pm EDT by the American College of Emergency Physicians (ACEP) during ACEP20?the world's largest emergency medicine...

at 11:35
The Oncology Institute of Hope and Innovation (TOI) is proud to announce that Omkar Marathe, MD, a TOI physician, has received the "40 Under 40 in Cancer" award. The 40 Under 40 in Cancer award celebrates the contributions of emerging leaders in...

News published on 24 september 2020 at 08:00 and distributed by: